Nicklin MJ, Weith A, Duff GW (Jan 1994). "A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes". Genomics19 (2): 382–4. PMID8188271. doi:10.1006/geno.1994.1076.
March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K (Aug 1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs". Nature315 (6021): 641–7. PMID2989698. doi:10.1038/315641a0.
Gery I, Handschumacher RE (Mar 1974). "Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells". Cellular Immunology11 (1–3): 162–9. PMID4549027. doi:10.1016/0008-8749(74)90016-1.
Watanabe N, Kobayashi Y (Nov 1994). "Selective release of a processed form of interleukin 1 alpha". Cytokine6 (6): 597–601. PMID7893968. doi:10.1016/1043-4666(94)90046-9.
Yin H, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (Aug 2001). "Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein". Cytokine15 (3): 122–37. PMID11554782. doi:10.1006/cyto.2001.0891.
Dorie MJ, Allison AC, Zaghloul MS, Kallman RF (May 1989). "Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine191 (1): 23–9. PMID2654945. doi:10.3181/00379727-191-42884.
Constine LS, Harwell S, Keng P, Lee F, Rubin P, Siemann D (Mar 1991). "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation". International Journal of Radiation Oncology, Biology, Physics20 (3): 447–56. PMID1995530. doi:10.1016/0360-3016(91)90056-A.
Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG (Mar 1993). "The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin". The New England Journal of Medicine328 (11): 756–61. PMID8437596. doi:10.1056/NEJM199303183281103.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA (January 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.". Cytokine89: 127–135. PMID26854213. doi:10.1016/j.cyto.2016.01.021.
Valente Duarte de Sousa IC (Oct 2014). "Novel pharmacological approaches for the treatment of acne vulgaris". Expert Opinion on Investigational Drugs23 (10): 1389–410. PMID24890096. doi:10.1517/13543784.2014.923401.
Nicklin MJ, Weith A, Duff GW (Jan 1994). "A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes". Genomics19 (2): 382–4. PMID8188271. doi:10.1006/geno.1994.1076.
March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K (Aug 1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs". Nature315 (6021): 641–7. PMID2989698. doi:10.1038/315641a0.
Dinarello CA (Jun 1997). "Induction of interleukin-1 and interleukin-1 receptor antagonist". Seminars in Oncology24 (3 Suppl 9): S9–81–S9–93. PMID9208877.
Gery I, Handschumacher RE (Mar 1974). "Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells". Cellular Immunology11 (1–3): 162–9. PMID4549027. doi:10.1016/0008-8749(74)90016-1.
Watanabe N, Kobayashi Y (Nov 1994). "Selective release of a processed form of interleukin 1 alpha". Cytokine6 (6): 597–601. PMID7893968. doi:10.1016/1043-4666(94)90046-9.
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (May 1986). "Interleukin 1 is present in normal human epidermis". Journal of Immunology136 (9): 3317–23. PMID3007615.
Schmitt A, Hauser C, Jaunin F, Dayer JM, Saurat JH (1986). "Normal epidermis contains high amounts of natural tissue IL 1 biochemical analysis by HPLC identifies a MW approximately 17 Kd form with a P1 5.7 and a MW approximately 30 Kd form". Lymphokine Research5 (2): 105–18. PMID3486328.
Yin H, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (Aug 2001). "Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein". Cytokine15 (3): 122–37. PMID11554782. doi:10.1006/cyto.2001.0891.
Neta R, Douches S, Oppenheim JJ (Apr 1986). "Interleukin 1 is a radioprotector". Journal of Immunology136 (7): 2483–5. PMID3512714.
Dorie MJ, Allison AC, Zaghloul MS, Kallman RF (May 1989). "Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine191 (1): 23–9. PMID2654945. doi:10.3181/00379727-191-42884.
Constine LS, Harwell S, Keng P, Lee F, Rubin P, Siemann D (Mar 1991). "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation". International Journal of Radiation Oncology, Biology, Physics20 (3): 447–56. PMID1995530. doi:10.1016/0360-3016(91)90056-A.
Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG (Mar 1993). "The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin". The New England Journal of Medicine328 (11): 756–61. PMID8437596. doi:10.1056/NEJM199303183281103.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA (January 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.". Cytokine89: 127–135. PMID26854213. doi:10.1016/j.cyto.2016.01.021.
Valente Duarte de Sousa IC (Oct 2014). "Novel pharmacological approaches for the treatment of acne vulgaris". Expert Opinion on Investigational Drugs23 (10): 1389–410. PMID24890096. doi:10.1517/13543784.2014.923401.